Global Drug Policy will be debated at the united nations in 2016.
The voice of physicians will be heard.
828
Physicians Signed
 
Target: 1500 by January 2015
2,500 by march 2015 | 5,000 by 2016
Join Now
UNGASS
Ketamine
Naloxone
Shadow
In The News
The road to the UN General Assembly Special Session on Drugs in 2016
There is a clear sense that attempts to stifle debate on both the failings of international drug policy and the possibility of exploring alternative approaches will not succeed.
EMCDDA director: Drug policies in the perspective of the UNGASS 2016 on drugs
Mr. Götz highlighted the EU's crucial role at the 2016 UNGASS, speaking with a unified voice to bring "more Europe" into world drugs policy.
The problem with treating pain in America
The number of opioid prescriptions for pain in the US has gone from 76 million in 1991 to 219 million in 2011.
Publications
The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a national institutes of health pathways to prevention workshop Increases in prescriptions of opioid medications for chronic pain have been accompanied by increases in opioid overdoses, abuse, and other harms and uncertainty about long-term effectiveness.
Human rights, drug control and the UN special prodedures This publication examines human rights violations - such as arbitrary detention - occurring as a consequence of drug control or enforcement efforts to control the illicit trade and consumption of certain drugs.
Trends in opioid analgesic abuse and mortality in the United States The use of prescription opioid medications has increased greatly in the United States during the past two decades; in 2010, there were 16,651 opioid-related deaths.